StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Brilinta / Brilique (ticagrelor) by Quarter

Brilinta / Brilique (ticagrelor) — Europe YoY actual (%) (%)

QuarterlyAnnual

AstraZeneca Brilinta / Brilique (ticagrelor): -79.0% in Q2 2026, down 53.0 pts from a year earlier. That is the lowest of the 23 quarters on record here.

Latest, Q2 2026
-79.0%
Period ended Jun 30, 2026
Change on a year earlier
-53.0 pts
-26.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Brilinta | | 80 | | ( 62 ) | | ( 63 ) | | 2 | | ( 98 ) | | 66 | | 5 | | 3 | | 11 | | ( 79 ) | | ( 80 ) | | 1 | | ( 31 ) | | ( 17 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBrilinta / Brilique (ticagrelor) — Europe YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-79.0%-53.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-77.0%-60.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-73.0%-69.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-66.0%-65.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-26.0%-27.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-17.0%-16.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-4.0%-5.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024-1.0%-5.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20241.0%+8.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-1.0%+11.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20231.0%+20.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20234.0%+27.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-7.0%+12.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023-12.0%+1.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-19.0%-17.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-23.0%-24.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Brilinta / Brilique (ticagrelor) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-brilinta-eu-act-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.